Shares of TG Therapeutics Inc. blasted off in very active trading Wednesday, after the biopharmaceutical company reported third-quarter results that were multiples above what was expected, as adoption of its multiple sclerosis treatment Briumvi “continues to grow.”
The stock TGTX shot up 26.7% in morning trading, which puts it on track for the biggest one-day gain since it ran up 63.4% on Nov. 10, 2022. Trading volume swelled to 24 million shares, compared with the full-day average over the past 30 days of about 4.3 million...
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: